Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8+ TCR-Vβ+ expansions-Reference-Cited by-同舟云学术

Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8+ TCR-Vβ+ expansions

Published:2018-02-07 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lissina Anna,McLaren James E.,Ilander Mette,Andersson Emma I.^ORCID,Lewis Catherine S.,Clement Mathew^ORCID,Herman Andrew,Ladell Kristin,Llewellyn-Lacey Sian,Miners Kelly L.,Gostick Emma,Melenhorst J. Joseph,Barrett A. John,Price David A.,Mustjoki Satu,Wooldridge Linda

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-18062-x.pdf

Reference50 articles.

1. Clemente, M. J. et al. Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes. Blood 122, 4077–4085, https://doi.org/10.1182/blood-2013-05-506386 (2013).

2. Clemente, M. J. et al. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood 118, 4384–4393, https://doi.org/10.1182/blood-2011-02-338517 (2011).

3. Melenhorst, J. J. et al. T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57. Hematol J 4, 18–25, https://doi.org/10.1038/sj.thj.6200212 (2003).

4. Sokol, L. & Loughran, T. P. Jr. Large granular lymphocyte leukemia. Curr Hematol Malig Rep 2, 278–282, https://doi.org/10.1007/s11899-007-0038-7 (2007).

5. Wlodarski, M. W., Schade, A. E. & Maciejewski, J. P. T-large granular lymphocyte leukemia: current molecular concepts. Hematology 11, 245–256, https://doi.org/10.1080/10245330600774793 (2006).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging;Pharmaceutics;2023-03-11

2. Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection;Frontiers in Pharmacology;2019-10-18